Krystal Biotech (KRYS) EBIT Margin (2023 - 2026)
Krystal Biotech's EBIT Margin was 49.00% in Q2 2026, up 7.98 percentage points from 41.02% a year earlier and up 2.87 percentage points from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) EBIT Margin (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Krystal Biotech's EBIT Margin was 44.89% through Jun 30, 2026, up 6.05 percentage points year-over-year; for FY2025, it came in at 41.45%, up 18.82 percentage points from FY2024.
- In earlier years, EBIT Margin was 22.63% in FY2024 (+238.84 pp) and -216.21% in FY2023.
- The Q2 2026 figure marks the highest quarterly EBIT Margin in data going back to Q3 2023.
- Compared with a year earlier, EBIT Margin was higher in seven of the last eight quarters, with an average year-over-year change of +59.68 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q3 2024 (a gain of 330.60 percentage points); the worst was Q4 2025 (a drop of 4.08 percentage points).
- Per Business Quant data, KRYS's EBIT Margin in the three quarters before Q2 2026 was 46.12% (Q1 2026), 41.33% (Q4 2025) and 42.30% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Krystal Biotech | 9.98 Bn | 6.75 Bn | 112.79 Mn | 49.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.00% |
| Mar 31, 2026 | 46.12% |
| Dec 31, 2025 | 41.33% |
| Sep 30, 2025 | 42.30% |
| Jun 30, 2025 | 41.02% |
| Mar 31, 2025 | 41.10% |
| Dec 31, 2024 | 45.41% |
| Sep 30, 2024 | 26.80% |
| Jun 30, 2024 | 12.18% |
| Mar 31, 2024 | -14.75% |
| Dec 31, 2023 | 7.71% |
| Sep 30, 2023 | -303.80% |
API Access
Krystal Biotech EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();